Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that involves the degeneration of motor nerve cells in the brain and spinal cord. As the disease progresses, muscles weaken to the point of total paralysis.
ALS affects about 3,000 Canadians. Most patients succumb to the disease within five years of diagnosis. There is no cure but progress has been made in recent years to enable patients to live longer and more productive lives.
The Neuro’s experts conduct advanced ALS research in collaboration with national and international partners. This includes basic, clinical and translational approaches to investigate the genetic causes, identify key biomarkers, pathways for future therapies and optimize care to improve the quality of life.
The ALS Clinic at The Neuro provides specialized care, support and education to patients and families from initial diagnosis to advanced stages of ALS. About 250 ALS patients are actively observed and treated at the Clinic. Between 60 and 80 new cases are diagnosed here each year.
The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.